Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 566

1.

Glycoprotein B from strain 17 of herpes simplex virus type I contains an invariant chain homologous sequence that binds to MHC class II molecules.

Sievers E, Neumann J, Raftery M, SchOnrich G, Eis-Hübinger AM, Koch N.

Immunology. 2002 Sep;107(1):129-35.

2.

Herpes simplex virus type 1 targets the MHC class II processing pathway for immune evasion.

Neumann J, Eis-Hübinger AM, Koch N.

J Immunol. 2003 Sep 15;171(6):3075-83.

3.
4.
5.

Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.

Thayer WP, Ignatowicz L, Weber DA, Jensen PE.

J Immunol. 1999 Feb 1;162(3):1502-9.

6.

A mutant human histocompatibility leukocyte antigen DR molecule associated with invariant chain peptides.

Mellins E, Cameron P, Amaya M, Goodman S, Pious D, Smith L, Arp B.

J Exp Med. 1994 Feb 1;179(2):541-9.

7.

A novel domain on HLA-DRbeta chain regulates the chaperone role of the invariant chain.

Neumann J, Koch N.

J Cell Sci. 2006 Oct 15;119(Pt 20):4207-14. Epub 2006 Sep 19.

8.

T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates.

Morkowski S, Goldrath AW, Eastman S, Ramachandra L, Freed DC, Whiteley P, Rudensky AYu.

J Exp Med. 1995 Nov 1;182(5):1403-13.

9.

Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins.

Harris PE, Maffei A, Colovai AI, Kinne J, Tugulea S, Suciu-Foca N.

Blood. 1996 Jun 15;87(12):5104-12.

10.

Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.

Weber DA, Evavold BD, Jensen PE.

Science. 1996 Oct 25;274(5287):618-20.

PMID:
8849454
11.
12.
13.

The herpes simplex virus-1 encoded glycoprotein B diverts HLA-DR into the exosome pathway.

Temme S, Eis-Hübinger AM, McLellan AD, Koch N.

J Immunol. 2010 Jan 1;184(1):236-43. doi: 10.4049/jimmunol.0902192. Epub 2009 Nov 30.

14.

Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.

van Ham SM, Grüneberg U, Malcherek G, Bröker I, Melms A, Trowsdale J.

J Exp Med. 1996 Nov 1;184(5):2019-24.

15.

More efficient peptide binding to MHC class II molecules during cathepsin B digestion of Ii than after Ii release.

Daibata M, Xu M, Humphreys RE, Reyes VE.

Mol Immunol. 1994 Mar;31(4):255-60.

PMID:
8139580
16.

Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR.

Vogt AB, Stern LJ, Amshoff C, Dobberstein B, Hämmerling GJ, Kropshofer H.

J Immunol. 1995 Nov 15;155(10):4757-65.

PMID:
7594477
17.
18.

Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Sloan VS, Cameron P, Porter G, Gammon M, Amaya M, Mellins E, Zaller DM.

Nature. 1995 Jun 29;375(6534):802-6.

PMID:
7596415
19.

The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.

Fujii S, Senju S, Chen YZ, Ando M, Matsushita S, Nishimura Y.

Hum Immunol. 1998 Oct;59(10):607-14.

PMID:
9757942
20.

Supplemental Content

Support Center